Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
China Resources Dubl Crne Phrmctl (600062 CH)
Watchlist
26
Analysis
Health Care
•
China
China Resources Double-Crane Pharmaceutical Co., Ltd. develops, manufactures and markets a variety of medical products. The Company's products include anti-influenza, antihypertensives, and antibiotics.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
China Resources Dubl Crne Phrmctl
•
07 Aug 2026 08:23
Primer: China Resources Dubl Crne Phrmctl (600062 CH) - Aug 2026
Dominant Player in Core Segments with Strategic Shift to Innovation: As a core subsidiary of the state-owned China Resources Pharmaceutical...
αSK Primers
83 Views
Share
bullish
•
Tencent
•
04 May 2024 00:35
Upgrading Emerging Markets to Market Weight; China/Hong Kong Continue to Bottom; Energy Breakdowns
Upgrading Emerging Markets $EEM $VWO to Market Weight; China/Hong Kong Continue to Bottom $FXI $MCHI $KWEB; Lows Likely in on $ACWI; Commodities...
Vermilion Research
Follow
696 Views
Share
bearish
•
Thematic (Sector/Industry)
•
11 Aug 2022 08:41
Will the Approval of Genuine Biotech's COVID-19 Oral Drug Change China's Zero-COVID Policy?
Due to VBP/fierce competition/weak demand, Azivudine's outlook is challenging.Until President Xi’s 3rd term appointment is confirmed,there’s no...
Xinyao (Criss) Wang
Follow
407 Views
Share
bearish
•
Thematic (Sector/Industry)
•
06 Oct 2016 21:27
Falling Fertility Adds to China's Population Woes
By allowing couples to have up to two children China hopes to reverse its likely population decline. But falling fertility and the pressures of...
Bixmoor
4.3k Views
Share
bearish
•
Thematic (Sector/Industry)
•
12 Sep 2016 23:18
Iran Shows China the Way on Population Expansion
Faced with dramatically falling birth rates, Iran has introduced a wide range of pro-natalist policies. In contrast, China has been half-hearted in...
Bixmoor
360 Views
Share
1
2
3
4
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x